Stivarga(regorafenib)
Stivarga 40 MG Oral Tablet

Dosage & Administration

Dosage & Administration

drug label

Stivarga Prescribing Information

prior authorization

Stivarga Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jul 26, 2024Arizona - Uniform Prior Authorization Form
Verified: Jul 26, 2024Colorado - Uniform Prior Authorization Form
Verified: Jul 26, 2024Hawaii - Uniform Prior Authorization Form
Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form
Verified: Jul 26, 2024Indiana - Uniform Prior Authorization Form
Verified: Jul 26, 2024Louisiana - Uniform Prior Authorization Form
Verified: Jul 26, 2024Minnesota - Uniform Prior Authorization Form
Verified: Jul 26, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Jul 26, 2024New Mexico - Uniform Prior Authorization Form
Verified: Jul 26, 2024Oregon - Uniform Prior Authorization Form
Verified: Jul 26, 2024Texas - Uniform Prior Authorization Form
Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form
Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

pharmacy

Stivarga Preferred Pharmacy

Pharmacy List

financial assistance

Stivarga Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program
Learn More

patient education

Stivarga Patient Education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

people also ask

Stivarga FAQs

How is the dosage of Stivarga?Stivarga is available in 1 dosages, including 40 mg Tab
What does Stivarga treat?Stivarga treats Hepatocellular Carcinoma, Colorectal Neoplasms and Gastrointestinal Stromal Tumors
What is Stivarga made of?Stivarga contains regorafenib which is a Kinase Inhibitor
How Is Stivarga Administered?Stivarga is administered as a Oral Pill
What Are The Stivarga Mechanism Of Action?Stivarga mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 2C9 Inhibitors, Kinase Inhibitors, UGT1A1 Inhibitors or UGT1A9 Inhibitors
FAQ Data Source